Prevalence, Risk Factors, and Comorbidities of Hidradenitis Suppurativa
Dermatologic Clinics, ISSN: 0733-8635, Vol: 34, Issue: 1, Page: 7-16
2016
- 131Citations
- 208Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations131
- Citation Indexes128
- 128
- CrossRef84
- Policy Citations2
- Policy Citation2
- Clinical Citations1
- PubMed Guidelines1
- Captures208
- Readers208
- 208
Review Description
It is challenging to estimate a true prevalence of hidradenitis suppurativa (HS) because it is underdiagnosed and misdiagnosed. Prevalences have been reported from 0.00033% to 4.1%. The incidence seems to be rising. In addition to dermatologic symptoms, HS is associated with metabolic syndrome, and increased cardiovascular risk. The majority of HS patients are smokers. Additional somatic comorbidities complicating HS include autoimmune conditions, follicular syndromes, rheumatologic conditions, and malignancies. HS patients are troubled by psychological comorbidities. When treating HS patients it is imperative not only to treat the skin symptoms, but also address the screening and treatment of possible comorbidities.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0733863515000984; http://dx.doi.org/10.1016/j.det.2015.08.002; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84961258386&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/26617352; https://linkinghub.elsevier.com/retrieve/pii/S0733863515000984; https://dx.doi.org/10.1016/j.det.2015.08.002
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know